Orofluco (Fluconazole)

Fluconazole works by inhibiting the fungal enzyme lanosterol 14α‑demethylase, a key step in the synthesis of ergosterol, an essential component of the fungal cell membrane. This inhibition disrupts membrane formation, leading to increased permeability and ultimately halting fungal growth and replication.

The dosage of Orofluco is individualized and prescribed by a qualified clinician. Dosing depends on the type and severity of the infection, patient age, weight, renal function, and other clinical factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of fluconazole during pregnancy and lactation depends on the indication, dose, and trimester. It is classified as a pregnancy‑category drug that may be used when the benefits outweigh potential risks. Breastfeeding mothers should discuss possible infant exposure with their healthcare provider before using Orofluco.

To request Orofluco, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other antifungal classes such as polyenes or echinocandins, fluconazole offers oral administration, a broad spectrum against Candida species, and good central nervous system penetration, making it suitable for cryptococcal meningitis. However, resistance can develop in some Candida strains, and it may have more drug‑interaction potential than agents with fewer cytochrome P450 effects.

Orofluco should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original container, protect them from moisture, heat and direct sunlight. Do not store in a bathroom or near a kitchen sink where humidity is high.

Orofluco is taken orally, usually with a glass of water. The tablet can be swallowed whole and may be taken with or without food, unless the prescribing clinician advises otherwise. Patients should follow the exact schedule and duration prescribed by their healthcare professional.

Serious risks include liver toxicity, severe skin reactions such as Stevens‑Johnson syndrome, and cardiac arrhythmias due to QT interval prolongation. Patients should be monitored for signs of jaundice, unexplained rash, or palpitations, and should seek immediate medical attention if these occur.

Orofluco is contraindicated in individuals with known hypersensitivity to fluconazole or any azole antifungal. Patients with significant liver disease, uncontrolled cardiac arrhythmias, or those taking medications that have a major interaction with fluconazole should avoid its use unless closely supervised by a physician.